Infrequent Reinfection after Successful Treatment for Hepatitis C Virus Infection in Injection Drug Users | Zendy

Markus Backmund | Zendy; Kirsten Meyer | Zendy; Brian R. Edlin | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Infrequent Reinfection after Successful Treatment for Hepatitis C Virus Infection in Injection Drug Users

Author(s) -

Markus Backmund,

Kirsten Meyer,

Brian R. Edlin

Publication year - 2004

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1086/425361

Subject(s) - medicine , virology , drug , hepatitis c virus , injection drug use , hepatitis c , virus , viral disease , immunology , intensive care medicine , drug injection , pharmacology

We followed-up 18 injection drug users for a mean of 33.8 months (range, 4-55 months) after successful treatment for hepatitis C virus (HCV) infection. Fifteen (83%) of the patients remained HCV RNA-negative, 1 patient was not tested, and 2 patients had test results positive for HCV RNA. The estimated rate of reinfection as a result of injection drug use was 0-4.1 cases per 100 person-years (cumulative incidence, 0%-12.6% at 48 months after completion of treatment). Of 50 patients originally treated, 15 (30%) were HCV RNA-negative 3 years later.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research